A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer
Condition: Non-muscle-invasive Bladder Cancer Intervention: Drug: STM-416 Sponsor: SURGE Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials